Found 1710 results for "cancer"
Understanding how cells know when to grow and when to stop is one of the central questions in cancer biology and tissue homeostasis research. A newly…
Cancer patients frequently report altered taste perception — a phenomenon long attributed to treatment side effects but whose biological origins remain poorly…
Understanding how cells regulate gene expression on sex chromosomes has broad implications for reproductive biology, fertility research, and even cancer…
Understanding why immunotherapy succeeds in some liver cancer patients but fails in others has been one of oncology's most pressing open questions. A new…
Declining childhood cancer mortality is one of oncology's genuine success stories, yet the pace of progress varies sharply by geography, socioeconomics, and…
For the millions of cancer patients who respond only partially — or not at all — to checkpoint immunotherapy, a fundamental biological question looms: why…
For the roughly 1–3% of non-small cell lung cancer patients harboring MET exon 14 skipping mutations, treatment sequencing decisions carry outsized…
For the roughly 70% of breast cancer patients whose tumors are estrogen receptor-positive, tamoxifen remains a cornerstone of treatment — yet a significant…
Ovarian cancer's brutal lethality — it remains the most fatal gynecological malignancy — stems partly from a biological feedback loop that conventional…
Colorectal cancer's molecular complexity keeps yielding unexpected drivers, and this finding reframes how non-coding RNA can act as a stabilizing shield for…
A brain tumor so rare it affects roughly one person per 30 million worldwide has finally yielded its molecular secret — and the mechanism is unlike almost…
One of the most frustrating barriers in cancer immunology is that leukemia cells frequently evade T-cell killing by downregulating MHC molecules — the surface…
Pancreatic cancer has long occupied one of oncology's most discouraging corners — a disease where five-year survival rates languish below 15% and where the…
For decades, cisplatin-based chemotherapy has been the default treatment for muscle-invasive bladder cancer, a disease that carries a five-year survival rate…
Pancreatic cancer has long represented one of oncology's most stubborn challenges — a disease where RAS mutations drive tumor growth in roughly 90% of cases…
Glioblastoma remains one of oncology's most intractable challenges, with median survival under 15 months despite aggressive treatment. A new molecular…
For decades, cisplatin-based chemotherapy has been the standard first-line treatment for muscle-invasive and metastatic bladder cancer — a disease with…
Chronic low-grade inflammation — inflammaging — is one of the most potent drivers of age-related disease, yet its molecular origins remain incompletely…
Checkpoint immunotherapy has transformed oncology, yet a substantial fraction of patients fail to respond — and the molecular reasons remain poorly…
Colorectal cancer's lethality lies less in the primary tumor than in its capacity to spread — and metastasis remains one of oncology's hardest problems. A new…